pTH (13-34) (human) structure
|
Common Name | pTH (13-34) (human) | ||
|---|---|---|---|---|
| CAS Number | 81306-64-1 | Molecular Weight | 2808.22 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C125H199N39O33S | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
Use of pTH (13-34) (human)pTH (13-34) (human) is apTH ((Human parathyroid hormone) fragment. |
| Name | Parathyroid Hormone Fragment 13-34 human |
|---|---|
| Synonym | More Synonyms |
| Description | pTH (13-34) (human) is apTH ((Human parathyroid hormone) fragment. |
|---|---|
| Related Catalog |
| Molecular Formula | C125H199N39O33S |
|---|---|
| Molecular Weight | 2808.22 |
| Exact Mass | 2806.48000 |
| PSA | 1236.13000 |
| LogP | 6.30010 |
| Index of Refraction | 1.66 |
| InChIKey | VFUXFEHDZJLJEA-HQIUGSBTSA-N |
| SMILES | CSCCC(NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(N)CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(=O)NC(CCC(=O)O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CC(=O)O)C(=O)NC(C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CC(N)=O)C(=O)NC(Cc1ccccc1)C(=O)O)C(C)C)C(C)C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
|
Analysis of the requirements for parathyroid hormone action in renal membranes with the use of inhibiting analogues.
J. Biol. Chem. 250 , 3199-3203, (1975) Two synthetic analogues of bovine parathyroid hormone (PTH) with NH2-terminal modifications, PTH-(3-34) and [desamino-Ala-1]PTH-(1-34), were found to lack agonist activity but to demonstrate antagonis... |
|
|
Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia.
Clin. J. Am. Soc. Nephrol. 1 , 525-531, (2006) Measurement of bioactive parathyroid hormone (PTH) is essential for optimal management of bone abnormalities in dialysis patients. This can be accomplished by PTH measurements using third-generation P... |
|
|
Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
Clin. Lab. 51 , 21-29, (2005) Most of what we know on PTH bioactivity has been associated with the first 34 amino acids of the PTH structure acting on the type I PTH/PTHrP receptor, leaving little place to the carboxyl-terminal st... |
| pTH (13-34) (human) |